MORE DETAILS COMING SOON

Clint left South Africa in 2002, as a chiropractor & sports therapist, to come and play rugby for Aspen, the National Champs. Like all rugby players, he started as a painter but quickly grew from there into massage therapist and personal trainer. His real knack was an almost miraculous result with bad spines, which led Barry Sternlicht, founder of Starwood hotels, to allow Clint to open Aspen Back & Body in the St Regis in 2005. Clint’s love for his clients was unmatched. Aspen Back and Body was a big hit, and people travelled from across the world to get out of pain and avoid surgery. The clinic was packed with world leaders, celebrities and over 40 of the Forbes 400 families. For those who couldn’t make it to Aspen, Clint bought the patent for a stretching device and started shipping IdealStretch across the world to help improve flexibility across the world.

Clint and his wife Jade’s 3rd child, Gabi, also born in Aspen, had a stroke at birth. Shocked at the difficulty in accessing a good pediatric neurologist, Clint vowed to take on a much larger challenge and improve access for families. Clint founded 2nd.MD, raising investment from several US billionaires and built a service allowing members to enjoy unprecedented access to doctors at MD Anderson, Mayo, Hopkins, Mass General etc for 2nd opinions via video. It’s a game changer and its clients now include Morgan Stanley, Starbucks, Chevron, Waste Management, Viacom and many more.

Most recently, Clint has once again, been funded by billionaires to build the Uber of healthcare. Medici is a bold initiative that will change the face of healthcare across the world and reestablish America as the healthcare leading innovator, not just leading spender. Leaders from Amazon, Ebay, and United Healthcare have joined the mission.

Michael Johnsrud, PhD, RPh is Executive Director of the Texas Center for Health Outcomes Research and Education (TxCORE) and a Senior Research Scientist in Health Outcomes at the College of Pharmacy at The University of Texas at Austin. Mike designs and conducts studies to analyze how prescription drugs, medical devices, and various patent interventions impact resource utilization and patient outcomes and quality of life.

He has particular expertise in prescription drug pricing, as well as coverage and reimbursement policy in Medicaid, Medicare, and private-sector health plans and the economics of the marketplace for community pharmacy and prescription drug benefit programs.

Mike was previously a Senior Vice President at Avalere Health in Washington, DC, where he led the Health Economics and Advanced Analytics Practice and provided strategic guidance to clients to generate the needed clinical and economic evidence to inform stakeholders in the marketplace to determine the value of various drugs, medical devices and interventions. Prior to joining Avalere, Mike was Associate Director of The Center for Pharmacoeconomic Studies at the College of Pharmacy at The University of Texas at Austin.